3 patents
Utility
Chimeric Adenoviral Vectors
6 Jul 23
The present disclosure provides chimeric adenoviral vectors comprising a nucleic acid encoding a coronavirus disease 2019 (COVID-19) protein and an adjuvant and methods for using the vectors to elicit an immune response to the SARS-CoV-2 protein in order to treat COVID-19.
Sean Tucker, Emery Dora
Filed: 4 Jun 21
Utility
Formulations for Small Intestinal Delivery of RSV and Norovirus Antigens
1 Dec 22
Provided herein are compositions and methods for generating an immunogenic response in humans.
George Trager, Sean Tucker, Leesun Kim, Ciaran Scallan
Filed: 2 Aug 22
Utility
Formulations for small intestinal delivery of RSV and norovirus antigens
6 Sep 22
Provided herein are compositions and methods for generating an immunogenic response in humans.
George Trager, Sean Tucker, Leesun Kim, Ciaran Scallan
Filed: 8 Jun 16
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first